Earlier this year at the University of Georgia it was released that new stem-cell based stroke treatment repairs damaged brain tissue, and, human clinical trials could begin as early as next year. Researchers at the university have developed a new treatment for stroke that reduces brain damage and accelerates the brain's natural healing tendencies in animal models.
The research team led by the university professors Steven Stice and Nasrul Hoda created a treatment called AB126 which are generated from human neural stem cells.
Following the administration of AB126, the researchers used MRI scans to measure brain atrophy rates. The results generated by the MRI scans were great.
In addition to mice and rats, the results were replicated by an associate professor of animal and dairy science, and fellow university members using other models of stroke.
Based on these preclinical results, plans are being made to begin human studies in 2019, said Stice.
"Until now, we had very little evidence specific to neural exosome treatment and the ability to improve motor function," said Stice. "Just days after stroke, we saw better mobility, improved balance and measurable behavioral benefits in treated animal models."
The company that has been developed has plans to expand this initiative beyond stroke for preclinical studies in epilepsy, TBI and spinal cord injuries later this year.
I plan to follow up on the current activity of the stem-cell stroke treatment and report back to you here.
God Bless, Peg
Fall seven times, stand up eight. -- Japanese proverb